Scarborough Advisors’s Caribou Biosciences CRBU Stock Holding History

Scarborough Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,420	Closed	-$16K	–	254
2026 Q1	$16K	Buy	+8,420	New	+$14.5K	﹤0.01%	376

Other funds holding CRBU

Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return

Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Nvest Wealth Strategies Powell, Ohio $160M AUM

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Scarborough Advisors's CRBU Position: Q2 2026 in Review

Scarborough Advisors sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 8,420 shares — an estimated $16K sold.

Scarborough Advisors first reported a position in CRBU in Q1 2026 and held it in 1 quarter. The position peaked at $16K in Q1 2026. 8 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Scarborough Advisors reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
Scarborough Advisors sold 8,420 Caribou Biosciences shares in Q2 2026, an estimated $16K.
Scarborough Advisors first reported a position in Caribou Biosciences in Q1 2026 and held it in 1 quarter.
Scarborough Advisors's Caribou Biosciences position peaked at $16K in Q1 2026.
8 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.